Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1976 May 22;114(10):889-92, 895.

M components-a review of 1242 cases.

A Ameis, H S Ko, W Pruzanski
PMCID: PMC1957075  PMID: 817789

Abstract

Among 1242 patients referred for immunologic investigation 1255 M components were detected in the serum. Of these patients 50.9% had multiple myeloma, 18.1% had nonmyelomatous malignant diseases such as macroglobulinemia, lymphoma, leukemia or cancer, 4.3% had connective tissue diseases, 2.5% had primary generalized amyloidosis (PGA) and the rest had various "benign" conditions. Whereas IgG was the commonest M component in multiple myeloma, connective tissue diseases and the other benign conditions, IgM was the commonest M component in lymphoma and leukemia; Bence Jones proteinemia was most frequently observed in PGA. The ratio of kappa to lambda light chains varied from 1.7:1 in IgG myeloma to 1:9 in IgD myeloma, and was 1:2.1 in PGA. Bence Jones protein was detected in 422 (66%) of 640 urine samples tested, the prevalence ranging from more than 70% in multiple myeloma and PGA to as low as 36% in various benign conditions. It is evident that the class and type of M components and the presence of Bence Jones proteinuria have no definite significance with regard to the diagnosis. Therefore, thorough investigation and follow-up at regular intervals are required when M components are detected.

Full text

PDF
889

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axelsson U., Bachmann R., Hällén J. Frequency of pathological proteins (M-components) om 6,995 sera from an adult population. Acta Med Scand. 1966 Feb;179(2):235–247. doi: 10.1111/j.0954-6820.1966.tb05453.x. [DOI] [PubMed] [Google Scholar]
  2. Danon F., Seligmann M. Transient human monoclonal immunoglobulins. Scand J Immunol. 1972;1(4):323–328. doi: 10.1111/j.1365-3083.1972.tb03297.x. [DOI] [PubMed] [Google Scholar]
  3. Fine J. M., Lambin P., Leroux P. Frequency of monoclonal gammapathy ('M components') in 13,400 sera from blood donors. Vox Sang. 1972;23(4):336–343. doi: 10.1111/j.1423-0410.1972.tb03468.x. [DOI] [PubMed] [Google Scholar]
  4. Hobbs J. R. Disturbances of the immunoglobulins. Sci Basis Med Annu Rev. 1966:106–127. [PubMed] [Google Scholar]
  5. Isobe T., Osserman E. F. Pathologic conditions associated with plasma cell dyscrasias: a study of 806 cases. Ann N Y Acad Sci. 1971 Dec 31;190:507–518. doi: 10.1111/j.1749-6632.1971.tb13560.x. [DOI] [PubMed] [Google Scholar]
  6. MacKechnie H. L., Ogryzlo M. A., Pruzanski W. Heterogeneity of IgM/IgG cryocomplexes: immunological-clinical correlation. J Rheumatol. 1975 Jun;2(2):225–240. [PubMed] [Google Scholar]
  7. Oberdorfer A., Schnauffer K., Lange H. J., Neiss A. Zur Verteilung von Paraproteinämien nach Geschlecht und Alter der Patienten, Paraprotein-Klassen, -Subklassen und -Leichtketten-Typen. Z Klin Chem Klin Biochem. 1973 Feb;11(2):51–64. [PubMed] [Google Scholar]
  8. Zawadzki Z. A., Edwards G. A. M-components in immunoproliferative disorders. Electrophoretic and immunologic analysis of 200 cases. Am J Clin Pathol. 1967 Oct;48(4):418–430. doi: 10.1093/ajcp/48.4.418. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES